Hospira in major US ketorolac recall
August 4, 2015Hospira is being dogged with manufacturing problems that have led to the recall of millions of vials of its painkilling …
Teva buys majority stake in genomic analysis firm
August 4, 2015Manufacturing and Production, Research and Development, Sales and Marketing CNS, Immuneering, Teva, central nervous system, genetic analysis
Teva has agreed to by a 51% equity share of genomic-analysis company Immuneering to advance treatments for diseases of the …
Shire in $300m Foresight acquisition
August 4, 2015Manufacturing and Production, Research and Development, Sales and Marketing FST-100, Foresight Biotherapeutics, Shire, conjunctivitis, dry eye, lifitegrast, pink eye
Shire has acquired Foresight Biotherapeutics for $300 million, as it looks to build its presence in eye diseases. The acquisition …
CSL completes $275m Novartis vaccines acquisition
August 3, 2015Manufacturing and Production, Sales and Marketing CSL, Novartis, acquisitions, asset swap, vaccines
CSL Limited has finalised its transaction to acquire Novartis’s global influenza vaccine business for $275 million. The move means Novartis …
AstraZeneca and Isis Pharma in $65m drugs collaboration
August 3, 2015Manufacturing and Production, Research and Development AstraZeneca, Isis Pharma, Isis Pharmaceuticals, antisense, drug R&D
Isis Pharmaceuticals and AstraZeneca have announced a strategic collaboration to discover and develop antisense therapies for cardiovascular, metabolic and renal …
Sir Malcolm Grant reappointed as NHS England chair
August 3, 2015Professor Sir Malcolm Grant has been re-appointed as Chair of NHS England from 31 October 2015 for a further three …
Working Life: Celgene’s Lee Heeson
August 3, 2015Medical Communications, Sales and Marketing Celgene, Lee Heeson
How did you find your way into your current role?My career has progressed from ‘carrying the bag’ for GlaxoSmithKline in …
Eleven companies accused in Romanian corruption probe
August 3, 2015Business Services, Medical Communications, Sales and Marketing China, Daily Telegraph, GSK, Roche, Romania, bribery, corruption
GSK and Roche are among eleven pharma firms being investigated for paying bribes to doctors in Romania to prescribe drugs. …
AbbVie’s Humira receives first European OK for skin condition
August 3, 2015Sales and Marketing AbbVie, Hidradenitis suppurativa, Humira, adalimumab
The European Commission has approved AbbVie’s Humira as a treatment for moderate-to-severe hidradenitis suppurativa – a chronic condition affecting the …
Encouraging first results from trial of Merck’s Ebola vaccine
July 31, 2015Research and Development, Sales and Marketing Africa, EBV, Ebola, Ebola virus, Ebola virus disease, Vaccine, WHO, World Health Organisation, guinea, vaccination
The first trial of an experimental Ebola vaccine suggests it provides high protection against the disease as early as ten …
UK patients ‘self-diagnose rather than visit GP’
July 31, 2015Medical Communications GP, General Practice, internet
One in five people in the UK admit to self-diagnosing illnesses rather than making a doctor’s appointment. Research published in …
ABPI consulting on Code of Conduct changes
July 31, 2015Medical Communications, Sales and Marketing ABPI Code, PMCPA, Prescription Medicines Code of Practice Authority, code of conduct
The division of the ABPI that sets rules governing industry behaviour is consulting on changes to reflect new rules on …
Doctors ‘distrust apps developed by pharma’ – survey
July 31, 2015Medical Communications France, GPs, Germany, Healthcare Technologies, UK, chronic disease, disease management, healthcare tech
A study of GPs in three European countries show GPs feel there is a role for healthcare technologies in disease …
Depomed rejects Horizon’s latest takeover bid
July 30, 2015Sales and Marketing Depomed, horizon, mergers and acquisitions, takeovers
Depomed has rejected Horizon Pharma’s latest bid, stating the proposal is ‘inadequate’ and ’undervalues’ the company. The Irish pharma company …
Sanofi sales boosted by rare disease and multiple sclerosis drugs
July 30, 2015Manufacturing and Production, Sales and Marketing Genzyme, Oliver Brandicourt, Sanofi, brandicourt, financial results
Sales at pharma giant Sanofi increased by 5% in the second quarter of 2016 to nearly €10 billion, its latest …
BMS to trial Opdivo in solid tumours
July 30, 2015Research and Development BMS, Bristol-Myers Squibb, Kyowa Hakko Kirin, Poteligeo, mogamulizumab, nivolumab, opdivo, solid tumours
Bristol-Myers Squibb will begin early-phase trials of its immuno-oncology treatment Opdivo with other cancer treatments, to see if the combination …
NICE restricts access to new hepatitis C treatments
July 29, 2015Sales and Marketing AbbVie, BMS, Bristol-Myers Squibb, Exviera, Gilead, NICE, daklinza, harvoni, hepatits C
NICE has recommended three new treatment options for hepatitis C in draft guidance – but has been criticised for excluding …
Takeda cancer drug gets EMA boost
July 29, 2015Research and Development, Sales and Marketing Takeda, ixazomib, multiple myeloma
The EMA has granted Takeda an accelerated assessment for its multiple myeloma drug, ixazomib. The Agency’s Committee for Medicinal Products …
David Khougazian announced as president of Sanofi Pasteur MSD
July 29, 2015Business Services, Research and Development, Sales and Marketing MSD, Merck, Sanofi Pasteur
Sanofi Pasteur and Merck have appointed David Khougazian as president of their joint company, Sanofi Pasteur MSD. David Khougazian joined …
Dr James Shannon joins Immodulon Therapeutics board of directors
July 29, 2015Research and Development, Sales and Marketing Immodulon
Dr James Shannon has joined Immodulon as a non-executive director with immediate effect. Bringing with him 30 years’ of experience …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
